Certain Laparoscopic Surgical Staplers, Reload Cartridges, and Components Thereof; Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, Public Interest, and Bonding, 47521 [2021-18313]

Download as PDF 47521 Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices Certain Laparoscopic Surgical Staplers, Reload Cartridges, and Components Thereof; Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, Public Interest, and Bonding National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Dynamic Spectrum Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Apple, Cupertino, CA, and Strathmore University, Nairobi, KENYA have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Dynamic Spectrum Alliance, Inc. intends to file additional written notifications disclosing all changes in membership. On September 1, 2020, Dynamic Spectrum Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on September 18, 2020 (85 FR 58390). The last notification was filed with the Department on May 4, 2021. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on May 25, 2021 (86 FR 28150). U.S. International Trade Commission. ACTION: Correction of notice. Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. information in support of the claim to Laura Bryant, Gilcrease Museum, 1400 N Gilcrease Museum Road, Tulsa, OK 74127, telephone (918) 596–2747, email laura-bryant@utulsa.edu, by September 24, 2021. After that date, if no additional claimants have come forward, transfer of control of the sacred objects and/or objects of cultural patrimony to the Minnesota Chippewa Tribe, Minnesota (Mille Lacs Band) may proceed. The Gilcrease Museum is responsible for notifying the Minnesota Chippewa Tribe, Minnesota (Mille Lacs Band) that this notice has been published. Dated: August 11, 2021. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2021–18270 Filed 8–24–21; 8:45 am] BILLING CODE 4312–52–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1167] AGENCY: Correction is made to notice 86 FR 46882, which was published on August 20, 2021. There is a typographical error in the investigation number on the first page caption section. The correct investigation number should read: Investigation No. 337–TA–1167. SUMMARY: [FR Doc. 2021–18264 Filed 8–24–21; 8:45 am] BILLING CODE P Drug Enforcement Administration [Docket No. DEA–872] khammond on DSKJM1Z7X2PROD with NOTICES Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Dynamic Spectrum Alliance, Inc. Notice is hereby given that, on August 10, 2021, pursuant to Section 6(a) of the VerDate Sep<11>2014 16:54 Aug 24, 2021 Jkt 253001 7360 7370 I I The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. The company plans to manufacture the above-listed controlled substances in bulk to produce finished dosage forms and conduct research to develop new drug products and for clinical studies. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Brian S. Besser, Acting Assistant Administrator. PO 00000 Frm 00053 Fmt 4703 DEPARTMENT OF JUSTICE Sfmt 4703 [Docket No. DEA–864] Importer of Controlled Substances Application: Cedarburg Pharmaceuticals Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Benuvia Therapeutics Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on SUMMARY: DEPARTMENT OF JUSTICE Schedule Drug Enforcement Administration Drug Enforcement Administration, Justice. ACTION: Notice of application. BILLING CODE 7020–02–P Marihuana ................................. Tetrahydrocannabinols ............. Drug code BILLING CODE P DEPARTMENT OF JUSTICE AGENCY: [FR Doc. 2021–18313 Filed 8–24–21; 8:45 am] Controlled substance [FR Doc. 2021–18234 Filed 8–24–21; 8:45 am] Bulk Manufacturer of Controlled Substances Application: Benuvia Therapeutics Inc. By order of the Commission. Issued: August 20, 2021. Lisa Barton, Secretary to the Commission. or before October 25, 2021. Such persons may also file a written request for a hearing on the application on or before October 25, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 1, 2021, Benuvia Therapeutics Inc., 2700 Oakmont Drive, Round Rock, Texas 78665, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Cedarburg Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written SUMMARY: E:\FR\FM\25AUN1.SGM 25AUN1

Agencies

[Federal Register Volume 86, Number 162 (Wednesday, August 25, 2021)]
[Notices]
[Page 47521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18313]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1167]


Certain Laparoscopic Surgical Staplers, Reload Cartridges, and 
Components Thereof; Commission Determination To Review in Part a Final 
Initial Determination Finding a Violation of Section 337; Schedule for 
Filing Written Submissions on the Issues Under Review and on Remedy, 
Public Interest, and Bonding

AGENCY: U.S. International Trade Commission.

ACTION: Correction of notice.

-----------------------------------------------------------------------

SUMMARY: Correction is made to notice 86 FR 46882, which was published 
on August 20, 2021. There is a typographical error in the investigation 
number on the first page caption section. The correct investigation 
number should read: Investigation No. 337-TA-1167.

    By order of the Commission.

    Issued: August 20, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021-18313 Filed 8-24-21; 8:45 am]
BILLING CODE 7020-02-P